• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据破坏性获取的药代动力学数据估算曲线下面积的置信区间。

Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.

作者信息

Gagnon R C, Peterson J J

机构信息

SmithKline Beecham Pharmaceuticals, Statistical Sciences Department (UP-4205), Collegeville, Pennsylvania 19426-0989, USA.

出版信息

J Pharmacokinet Biopharm. 1998 Feb;26(1):87-102. doi: 10.1023/a:1023228925137.

DOI:10.1023/a:1023228925137
PMID:9773394
Abstract

The area under the curve (AUC) of the concentration-time curve for a drug or metabolite, and the variation associated with the AUC, are primary results of most pharmacokinetic (PK) studies. In nonclinical PK studies, it is often the case that experimental units contribute data for only a single time point. In such cases, it is straightforward to apply noncompartmental methods to determine an estimate of the AUC. In this report, we investigate noncompartmental estimation of the AUC using the long-trapezoidal rule during the elimination phase of the concentration-time profile, and we account for the underlying distribution of data at each sampling time. For data that follow a normal distribution, the log-trapezoidal rule is applied to arithmetic means at each time point of the elimination phase of the concentration-time profile. For data that follow a lognormal distribution, as is common with PK data, the log-trapezoidal rule is applied to geometric means at each time point during elimination. Since the log-trapezoidal rule incorporates nonlinear combinations of mean concentrations at each sampling time, obtaining an estimate of the corresponding variation about the AUC is not straightforward. Estimation of this variance is further complicated by the occurrence of lognormal data. First-order approximations to the variance of AUC estimates are derived under the assumptions of normality, and lognormality, of concentrations at each sampling time. AUC estimates and variance approximations are utilized to form confidence intervals. Accuracies of confidence intervals are tested using simulation studies.

摘要

药物或代谢物浓度-时间曲线的曲线下面积(AUC)以及与AUC相关的变异,是大多数药代动力学(PK)研究的主要结果。在非临床PK研究中,通常实验单位仅为单个时间点提供数据。在这种情况下,应用非房室方法来确定AUC的估计值很简单。在本报告中,我们研究了在浓度-时间曲线的消除阶段使用长梯形法则对AUC进行非房室估计,并考虑了每个采样时间数据的潜在分布。对于服从正态分布的数据,在浓度-时间曲线消除阶段的每个时间点,将对数梯形法则应用于算术平均值。对于服从对数正态分布的数据(PK数据常见),在消除过程中的每个时间点,将对数梯形法则应用于几何平均值。由于对数梯形法则包含了每个采样时间平均浓度的非线性组合,因此获得AUC相应变异的估计值并不简单。对数正态数据的出现使该方差的估计更加复杂。在每个采样时间浓度服从正态分布和对数正态分布的假设下,推导了AUC估计值方差的一阶近似值。利用AUC估计值和方差近似值来形成置信区间。通过模拟研究检验置信区间的准确性。

相似文献

1
Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.根据破坏性获取的药代动力学数据估算曲线下面积的置信区间。
J Pharmacokinet Biopharm. 1998 Feb;26(1):87-102. doi: 10.1023/a:1023228925137.
2
[Review of a technic for the estimation of area under the concentration curve in pharmacokinetic analysis].[药代动力学分析中浓度曲线下面积估算技术的综述]
Therapie. 1993 Jan-Feb;48(1):1-5.
3
The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.样本合并方法在药代动力学研究中用于确定曲线下面积(AUC)、一阶矩曲线下面积(AUMC)和平均驻留时间的应用。
Fundam Clin Pharmacol. 2005 Jun;19(3):347-54. doi: 10.1111/j.1472-8206.2005.00329.x.
4
Optimising time samples for determining area under the curve of pharmacokinetic data using non-compartmental analysis.优化时间样本,使用非房室分析确定药代动力学数据的曲线下面积。
J Pharm Pharmacol. 2019 Nov;71(11):1635-1644. doi: 10.1111/jphp.13154. Epub 2019 Aug 14.
5
Pharmacokinetics and bioequivalence studies of galantamine hydrobromide dispersible tablet in healthy male Chinese volunteers.
Drug Dev Ind Pharm. 2007 Mar;33(3):335-40. doi: 10.1080/03639040600868011.
6
An evaluation of numerical integration algorithms for the estimation of the area under the curve (AUC) in pharmacokinetic studies.药代动力学研究中用于估计曲线下面积(AUC)的数值积分算法评估。
Biopharm Drug Dispos. 1995 Jan;16(1):37-58. doi: 10.1002/bdd.2510160105.
7
Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental design.在毒代动力学实验设计中使用参数法和非参数法时曲线下面积置信区间的覆盖范围和精度。
Pharm Res. 1998 Mar;15(3):405-10. doi: 10.1023/a:1011968129921.
8
Construction of an optimal destructive sampling design for noncompartmental AUC estimation.
J Pharmacokinet Biopharm. 1999 Apr;27(2):191-212. doi: 10.1023/a:1020606006936.
9
Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data.使用群体药代动力学模型和自抽样法比较替诺福韦的血浆和组织暴露:基于观察数据的模拟研究
J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):631-640. doi: 10.1007/s10928-017-9554-9. Epub 2017 Nov 8.
10
Numerical estimation of the noncompartmental pharmacokinetic parameters variance and coefficient of variation of residence times.
J Pharm Sci. 1994 Feb;83(2):202-5. doi: 10.1002/jps.2600830217.

引用本文的文献

1
Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance.长效注射剂中的部分AUC:原理、挑战、变异性、实用性及临床相关性
Pharmaceutics. 2024 Dec 26;17(1):21. doi: 10.3390/pharmaceutics17010021.
2
Two-Step Transfer Learning Improves Deep Learning-Based Drug Response Prediction in Small Datasets: A Case Study of Glioblastoma.两步迁移学习改善小数据集中基于深度学习的药物反应预测:胶质母细胞瘤案例研究
Bioinform Biol Insights. 2025 Jan 3;19:11779322241301507. doi: 10.1177/11779322241301507. eCollection 2025.
3
New Application of an Old Drug: Anti-Diabetic Properties of Phloroglucinol.

本文引用的文献

1
A note on testing areas under the curve when using destructive measurement techniques.关于使用破坏性测量技术时曲线下面积测试的说明。
J Pharmacokinet Biopharm. 1996 Dec;24(6):651-5. doi: 10.1007/BF02353485.
2
Performance of Bailer's method for AUC confidence intervals from sparse non-normally distributed drug concentrations in toxicokinetic studies.在毒物动力学研究中,Bailer方法用于从稀疏的非正态分布药物浓度计算AUC置信区间的性能。
Pharm Res. 1996 Sep;13(9):1280-2. doi: 10.1023/a:1016045210765.
3
Randomization tests for assessing the equality of area under curves for studies using destructive sampling.
旧药新用:间苯三酚的抗糖尿病特性。
Int J Mol Sci. 2024 Sep 24;25(19):10291. doi: 10.3390/ijms251910291.
4
Association of neutrophil-to-lymphocyte ratio with age and 180-day mortality after emergency surgery.中性粒细胞与淋巴细胞比值与急诊手术后年龄和 180 天死亡率的关系。
BMC Anesthesiol. 2024 Sep 17;24(1):329. doi: 10.1186/s12871-024-02718-z.
5
Brief cycling intervals incrementally increase the number of hematopoietic stem and progenitor cells in human peripheral blood.短暂的循环间隔会逐渐增加人类外周血中造血干细胞和祖细胞的数量。
Front Physiol. 2024 Jul 30;15:1327269. doi: 10.3389/fphys.2024.1327269. eCollection 2024.
6
Comparison of serum SDMA and creatinine as a biomarker for the detection of meloxicam-induced kidney injury in cats.血清对称二甲基精氨酸(SDMA)与肌酐作为检测猫美洛昔康诱导的肾损伤生物标志物的比较。
Front Vet Sci. 2024 May 15;11:1395505. doi: 10.3389/fvets.2024.1395505. eCollection 2024.
7
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.在中低收入国家,用于检测高危恶性进展的宫颈病变的高性能甲基化 DNA 标志物的发现和技术验证。
Clin Epigenetics. 2024 Apr 20;16(1):56. doi: 10.1186/s13148-024-01669-z.
8
Continuous glucose monitoring captures glycemic variability in obesity after sleeve gastrectomy: A prospective cohort study.持续葡萄糖监测捕捉袖状胃切除术后肥胖患者的血糖变异性:一项前瞻性队列研究。
Obes Sci Pract. 2024 Jan 4;10(1):e729. doi: 10.1002/osp4.729. eCollection 2024 Feb.
9
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection.一种用于治疗肺部耐甲氧西林金黄色葡萄球菌感染的脂糖肽干粉吸入疗法的临床前研究。
Pharmaceutics. 2023 Aug 31;15(9):2250. doi: 10.3390/pharmaceutics15092250.
10
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.威帕他尼是一种药理先进的 RET 选择性抑制剂,具有较高的中枢神经系统穿透性和对 RET 溶剂前沿突变的抑制活性。
Nat Cancer. 2023 Sep;4(9):1345-1361. doi: 10.1038/s43018-023-00630-y. Epub 2023 Sep 21.
用于评估采用破坏性抽样的研究中曲线下面积相等性的随机化检验。
J Appl Toxicol. 1996 Sep-Oct;16(5):391-5. doi: 10.1002/(SICI)1099-1263(199609)16:5<391::AID-JAT363>3.0.CO;2-C.
4
The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics.用于毒物动力学中稀疏、破坏性采样的更好的AUC估计器的方差。
J Pharm Sci. 1996 Aug;85(8):884-6. doi: 10.1021/js960083a.
5
Estimation of variance for AUC in animal studies.动物研究中AUC方差的估计。
J Pharm Sci. 1993 Jul;82(7):761-3. doi: 10.1002/jps.2600820718.
6
Applying Bailer's method for AUC confidence intervals to sparse sampling.将贝勒法用于AUC置信区间的稀疏抽样。
Pharm Res. 1995 Jan;12(1):124-8. doi: 10.1023/a:1016255124336.
7
Testing for the equality of area under the curves when using destructive measurement techniques.
J Pharmacokinet Biopharm. 1988 Jun;16(3):303-9. doi: 10.1007/BF01062139.
8
Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.对使用线性梯形法则方法计算血浆浓度-时间曲线下面积的药代动力学研究中潜在误差的批判性评估。
J Pharmacokinet Biopharm. 1978 Dec;6(6):539-46. doi: 10.1007/BF01062108.
9
A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.
J Pharmacokinet Biopharm. 1978 Feb;6(1):79-98. doi: 10.1007/BF01066064.